Literature DB >> 8931294

Cell proliferation in renal cell carcinoma--a comparative study of cell kinetic methods.

P Larsson1, G Roos, R Stenling, G D Wilson, B Ljungberg.   

Abstract

Four different methods of assessing cell proliferation in renal cell carcinoma were compared in a total of 136 samples to analyze their degree of agreement and usefulness. The methods compared were flow cytometric S-phase (S-FCM) analysis, proliferating cell nuclear antigen expression detected by immunohistochemistry (PCNA-IHC), in vivo iododeoxyuridine incorporation analyzed with immunohistochemistry (IdUrd-IHC), and flow cytometry (IdUrd-FCM). The mean S-FCM fraction was 5.9%, compared with a mean PCNA-IHC labeling index of 4.7%. The mean labeling indices obtained by IdUrd-IHC and IdUrd-FCM were 1.2% and 1.7%, respectively. The four methods correlated well with each other. When the methods were compared according to Bland and Altman, good agreement was shown. A statistically significant difference in proliferation between diploid and aneuploid tumor samples was found with all methods (P < 0.001). The results showed that the four different methods provided comparable information on proliferative activity, although different cell cycle compartments were monitored.

Entities:  

Mesh:

Substances:

Year:  1996        PMID: 8931294     DOI: 10.1007/bf00304779

Source DB:  PubMed          Journal:  Urol Res        ISSN: 0300-5623


  20 in total

1.  Bromodeoxyuridine and deoxyribonucleic acid bivariate analysis in human renal cell carcinoma. Does flow cytometric determination predict malignant potential or prognosis of patients with renal cell carcinoma?

Authors:  M Tachibana; N Deguchi; S Baba; S Jitsukawa; M Hata; H Tazaki
Journal:  Am J Clin Pathol       Date:  1992-05       Impact factor: 2.493

2.  Statistical methods for assessing agreement between two methods of clinical measurement.

Authors:  J M Bland; D G Altman
Journal:  Lancet       Date:  1986-02-08       Impact factor: 79.321

3.  Prognostic value of proliferating cell nuclear antigen in gastric carcinoma.

Authors:  S Jain; M I Filipe; P A Hall; N Waseem; D P Lane; D A Levison
Journal:  J Clin Pathol       Date:  1991-08       Impact factor: 3.411

4.  Proliferating cell nuclear antigen expression in renal cell carcinoma. Prognostic implications.

Authors:  P Larsson; G Roos; R Stenling; B Ljungberg
Journal:  Scand J Urol Nephrol       Date:  1996-12

5.  Identity of the proliferating cell nuclear antigen and cyclin.

Authors:  M B Mathews; R M Bernstein; B R Franza; J I Garrels
Journal:  Nature       Date:  1984 May 24-30       Impact factor: 49.962

6.  The applications of the BrdUrd-technique for the estimation of cycling S-phase cells in human renal cell carcinoma.

Authors:  E M Langer; J Hemmer; G Kleinhans; W Göhde
Journal:  Urol Res       Date:  1988

7.  DNA content in renal cell carcinoma with reference to tumor heterogeneity.

Authors:  B Ljungberg; R Stenling; G Roos
Journal:  Cancer       Date:  1985-08-01       Impact factor: 6.860

8.  Proliferation of human renal cell carcinoma studied with in vivo iododeoxyuridine labelling and immunohistochemistry.

Authors:  P Larsson; G Roos; R Stenling; B Ljungberg
Journal:  Scand J Urol Nephrol       Date:  1994-06

9.  Comparative flow cytometric analysis of proliferating cell nuclear antigen (PCNA) antibodies in human solid neoplasms.

Authors:  K Teague; A el-Naggar
Journal:  Cytometry       Date:  1994-01-01

10.  Measurement of cell kinetics in human tumours in vivo using bromodeoxyuridine incorporation and flow cytometry.

Authors:  G D Wilson; N J McNally; S Dische; M I Saunders; C Des Rochers; A A Lewis; M H Bennett
Journal:  Br J Cancer       Date:  1988-10       Impact factor: 7.640

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.